New Breakthrough Treatment For Spinal Cancer Patients
New research has identified a potential treatment that could improve the human immune system’s ability to search out and destroy cancer cells within the body. Scientists have identified a way to restrict the activity of a group of cells that regulate the immune system, which in turn ...
liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases. Recent medical advancement made a new breakthrough treatment available for patients with hepatitis C. DAAs that block replication of...
Cullinan Oncology announced that the FDA has granted Breakthrough Therapy Designation for CLN-081 for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (“NSCLC”) harboring epidermal growth factor (“EGFR”) exon 20 in...
LOS ANGELES, April 23 (Xinhua) -- An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, according to a new study of the University of Southern Californ...
The FDA grantsBreakthrough Therapy designation— a process that expedites the development and review process for drugs that show significant promise—for the treatment. “This is based on data we had for 59 patients with metastatic cancer, all of whom had already failed one or more prior lines...
MELBOURNE, June 14 (Xinhua) -- A fresh breakthrough by a Melbourne cancer center could help patients, many of them babies, overcome acute myeloid leukaemia (AML). The Peter MacCallum Cancer Centre, a leading Australian facility for cancer research and treatment, made the discovery after combining...
“This describes a new concept of immunogenic cell injury rather than immunogenic cell death for cancer treatment,” Yaffe says. “We showed that if you treated tumor cells in a dish, when you injected them back directly into the tumor and gave checkpoint blockade inhibitors, the live, injured...
Some mice lived as long as 43 months. By doing this, they could assess the physical function and overall health changes of each mouse throughout the entire treatment period. Since each mouse died at a different age, this approach also allows Xu’s team to evaluate health status in the...
A new study has revealed a promising new treatment method for late-stage non-small cell lung cancer (NSCLC). The research, published in the Annals of Oncology, compared the efficacy and safety of two different treatments: nanoparticle polymeric micellar paclitaxel (pm-Pac) plus cisplatin and solv...